侵袭性乳腺癌的临床试验
总计54613个结果
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Hoffmann-La Roche; Brigham and Women's Hospital终止
-
Dana-Farber Cancer InstitutePfizer完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 浸润性小叶乳腺癌 | 浸润性导管癌美国, 波多黎各
-
H. Lee Moffitt Cancer Center and Research InstituteAmgen主动,不招人
-
University Medical Center GroningenMartini Hospital Groningen招聘中
-
Seoul National University HospitalMinistry of Health & Welfare, Korea招聘中
-
Istari Oncology, Inc.United States Department of Defense; Duke University完全的
-
Institut Claudius Regaud主动,不招人
-
Ohio State University Comprehensive Cancer CenterBarnes-Jewish Hospital完全的
-
Massachusetts General HospitalNational Cancer Institute (NCI)未知
-
University of NottinghamAstraZeneca; Cancer Research UK; National Cancer Research Network完全的
-
Centre hospitalier de l'Université de Montréal...Quebec Breast Cancer Foundation完全的
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)招聘中
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
NSABP Foundation IncGlaxoSmithKline未知
-
Fondazione MichelangeloHoffmann-La Roche主动,不招人
-
University of Alabama at BirminghamGenentech, Inc.; Ortho Biotech, Inc.完全的
-
University College, LondonNational Institute for Health Research, United Kingdom完全的
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead Sciences主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | HER2 阴性乳腺癌 | HR 阳性乳腺癌美国
-
Sindh Institute of Urology and Transplantation完全的